Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

Exclusive interview

Charles River mulls moonshots and mouse models

24-May-2016 - Charles River Laboratories are conducting new studies using animal models to give insight into therapeutic strategies where pharma companies expect to see the most success.

Crown Bioscience launches high throughput service platform

23-May-2016 - Crown Bioscience has launched an oncology service platform to improve preclinical studies using patient-derived xenograft (PDX) models.

Preclinical outsourcing to grow 20% in 2016 says new report

17-May-2016 - More drug discovery work will be outsourced this year according to a report which suggests pharmaceutical industry desire to reduce the risk of failure and cut costs persists.

Microbiome research tool developed for drug development

16-May-2016 - Researchers have developed an organ-on-a-chip model that will allow for preclinical testing in an environment analogous to the human gastrointestinal tract.

New mouse model, new opportunities for Zika research

12-May-2016 - Researchers have developed a new mouse model that allows them to ask different questions about the effects of the Zika virus.

Mass Innovation Labs: the evolution of R&D

05-May-2016 - Mass Innovation Labs is working to change the way biopharmaceutical companies conduct research by providing a “crossroads” for CRO service providers, vendors, and investors.

Elsevier’s ‘Hive Project’ to promote drug discovery

02-May-2016 - As a significant amount of drug discoveries occur outside of pharma companies, Elsevier has launched The Hive Project to promote innovation in the market – outside its walls.

‘Dirty mice’ better mirror humans, says researcher

25-Apr-2016 - Mice are used to model various human diseases – yet the animals don’t replicate some significant features of the adult human immune system.

Stem cells form tiny beating heart for drug testing

22-Apr-2016 - While there are currently several techniques for producing tissue from heart cells, a new method reduces the amount of cells needed, making it easier and cheaper to replicate.

Aptuit bolsters its preclinical services with Exquiron acquisition

21-Apr-2016 - Aptuit has acquired Swiss CRO Exquiron Biotech, enhancing its drug identification and validation services.

Johnson Matthey and Domainex team on API discovery and development

19-Apr-2016 - Johnson Matthey has teamed up with Domainex to offer integrated API discovery, preclinical development and manufacturing services. 

Building a better biomedical knowledgebase

18-Apr-2016 - Researchers as The Scripps Research Institute (TSRI) are working to create a public database where researchers can easily access biomedical knowledge.

Pierre Fabre signs on second partner to innovation program

14-Apr-2016 - Pierre Fabre laboratories has established a partnership with a biotech company as part of its Open Innovation program, "Nature Open Library."

Zika vaccine-blocker candidate being tested in animals

14-Apr-2016 - Replikins’ genomic understanding of the Zika and Flaviviruses has led to the development of a trivalent vaccine for Zika, Dengue, and Japanese Encephalitis. 

US 'foots the bill' for global biopharma innovation, says ITIF

12-Apr-2016 - The US ranks first in terms of how its domestic policies contribute to global biopharmaceutical innovation, according to a recent analysis.

Vaccines and biologics driving Charles River investments

12-Apr-2016 - Demand for biological products has driven recent investments in vaccine manufacturing and cell banking, says Charles River Laboratories.

New program to expedite clinical trials through data sharing

11-Apr-2016 - Finding the right patients quickly is an ongoing problem in launching clinical trials, so several companies have formed an alliance to advance precision medicine development. 

Microbial or mammalian? BioSilta backs the former licensing E. Coli platform

08-Apr-2016 - Microbial expression systems are cheaper and more efficient than mammalian cell cultures says BioSilta which has acquired the rights to an E. coli based platform.

Mouse model to aid Zika vaccine testing

06-Apr-2016 - Researchers have established a new mouse model for testing vaccines and therapeutics to fight the Zika virus.

CrownBio develops mouse strains with human PD-1 for mAb testing

05-Apr-2016 - Crown Bioscience has developed humanized mouse cancer models which it claims provide biologic drug developers with an improved means of assessing efficacy.

Pharma Consortium to investigate new drug development technique

04-Apr-2016 - The new consortium will evaluate cryo-electron microscopy’s potential for drug development.

SGS and DiscoverX to supply bioassays for biosimilar development

04-Apr-2016 - SGS has teamed with DiscoverX to offer bioassays for assessing the potency of prospective biosimilars of Roche’s Avastin and BMS’s Erbitux.

Eurofins agrees to buy US analytical services firm Advantar Laboratories

01-Apr-2016 - Eurofins Scientific has agreed to buy analytical services firm Advantar Laboratories in its latest deal in the pharmaceutical space.

New WCG board to advise on gene therapy research

30-Mar-2016 - WIRB-Copernicus Group (WCG) has assembled a team of experts to advise the company as it advances its gene therapy research. 

AAALAC accreditation for Envigo lab in the Netherlands

29-Mar-2016 - Lab animal treatment watchdog AAALAC has accredited an Envigo models facility and distribution centre in the Netherlands.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...